Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison

Background Differentiating infants with adverse events following immunisation (AEFIs) or invasive bacterial infection (IBI) is a significant clinical challenge. Young infants post vaccination are therefore often admitted to the hospital for parenteral antibiotics to avoid missing rare cases of IBI.M...

Full description

Bibliographic Details
Main Authors: Matthew D Snape, Daniel O'Connor, Emily Tough, Samuel William Channon-Wells
Format: Article
Language:English
Published: BMJ Publishing Group 2022-10-01
Series:BMJ Paediatrics Open
Online Access:https://bmjpaedsopen.bmj.com/content/6/1/e001559.full
_version_ 1797777445611372544
author Matthew D Snape
Daniel O'Connor
Emily Tough
Samuel William Channon-Wells
author_facet Matthew D Snape
Daniel O'Connor
Emily Tough
Samuel William Channon-Wells
author_sort Matthew D Snape
collection DOAJ
description Background Differentiating infants with adverse events following immunisation (AEFIs) or invasive bacterial infection (IBI) is a significant clinical challenge. Young infants post vaccination are therefore often admitted to the hospital for parenteral antibiotics to avoid missing rare cases of IBI.Methods During a service evaluation project, we conducted a single-centre retrospective observational study of infants with IBI, urinary tract infection (UTI) or AEFI from two previously published cohorts. All patients presented to hospital in Oxfordshire, UK, between 2011 and 2018, spanning the introduction of the capsular group-B meningococcal vaccine (4CMenB) into routine immunisation schedules. Data collection from paper and electronic notes were unblinded. Clinical features, including National Institute for Health and Care Excellence (NICE) ‘traffic light’ risk of severe illness and laboratory tests performed on presentation, were described, and comparisons made using regression models, adjusting for age and sex. We also compared biochemical results on presentation to those of well infants post vaccination, with and without 4CMenB regimens.Results The study included 232 infants: 40 with IBI, 97 with probable AEFI, 24 with possible AEFI, 27 with UTI and 44 post vaccination ‘well’ infants. C-reactive protein (CRP) was the only discriminatory blood marker, with CRP values above 83 mg/L only observed in infants with IBI or UTI. NICE risk stratification was significantly different between groups but still missed cases of IBI, and classification as intermediate risk was non-differential. Fever was more common in probable AEFI cases, while seizures and rashes were equally frequent. Diarrhoea and clinician-reported irritability or rigours were all more common in IBI.Conclusions Clinical features on presentation may aid risk stratification but cannot reliably differentiate IBI from AEFI in infants presenting to the emergency department. Blood results are generally unhelpful due to post vaccination inflammatory responses, particularly in children receiving 4CMenB vaccination. Improved biomarkers and clinical prediction tools are required to aid management in febrile infants post vaccination.
first_indexed 2024-03-12T23:05:04Z
format Article
id doaj.art-c99e17827af342158cc634b295a85e4a
institution Directory Open Access Journal
issn 2399-9772
language English
last_indexed 2024-03-12T23:05:04Z
publishDate 2022-10-01
publisher BMJ Publishing Group
record_format Article
series BMJ Paediatrics Open
spelling doaj.art-c99e17827af342158cc634b295a85e4a2023-07-19T05:00:07ZengBMJ Publishing GroupBMJ Paediatrics Open2399-97722022-10-016110.1136/bmjpo-2022-001559Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparisonMatthew D Snape0Daniel O'Connor1Emily Tough2Samuel William Channon-Wells31 Department of Paediatrics, University of Oxford, Oxford, UKOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UKOxford University Hospitals NHS Foundation Trust, Oxford, UKOxford University Hospitals NHS Foundation Trust, Oxford, UKBackground Differentiating infants with adverse events following immunisation (AEFIs) or invasive bacterial infection (IBI) is a significant clinical challenge. Young infants post vaccination are therefore often admitted to the hospital for parenteral antibiotics to avoid missing rare cases of IBI.Methods During a service evaluation project, we conducted a single-centre retrospective observational study of infants with IBI, urinary tract infection (UTI) or AEFI from two previously published cohorts. All patients presented to hospital in Oxfordshire, UK, between 2011 and 2018, spanning the introduction of the capsular group-B meningococcal vaccine (4CMenB) into routine immunisation schedules. Data collection from paper and electronic notes were unblinded. Clinical features, including National Institute for Health and Care Excellence (NICE) ‘traffic light’ risk of severe illness and laboratory tests performed on presentation, were described, and comparisons made using regression models, adjusting for age and sex. We also compared biochemical results on presentation to those of well infants post vaccination, with and without 4CMenB regimens.Results The study included 232 infants: 40 with IBI, 97 with probable AEFI, 24 with possible AEFI, 27 with UTI and 44 post vaccination ‘well’ infants. C-reactive protein (CRP) was the only discriminatory blood marker, with CRP values above 83 mg/L only observed in infants with IBI or UTI. NICE risk stratification was significantly different between groups but still missed cases of IBI, and classification as intermediate risk was non-differential. Fever was more common in probable AEFI cases, while seizures and rashes were equally frequent. Diarrhoea and clinician-reported irritability or rigours were all more common in IBI.Conclusions Clinical features on presentation may aid risk stratification but cannot reliably differentiate IBI from AEFI in infants presenting to the emergency department. Blood results are generally unhelpful due to post vaccination inflammatory responses, particularly in children receiving 4CMenB vaccination. Improved biomarkers and clinical prediction tools are required to aid management in febrile infants post vaccination.https://bmjpaedsopen.bmj.com/content/6/1/e001559.full
spellingShingle Matthew D Snape
Daniel O'Connor
Emily Tough
Samuel William Channon-Wells
Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison
BMJ Paediatrics Open
title Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison
title_full Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison
title_fullStr Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison
title_full_unstemmed Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison
title_short Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison
title_sort differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4cmenb era a retrospective observational comparison
url https://bmjpaedsopen.bmj.com/content/6/1/e001559.full
work_keys_str_mv AT matthewdsnape differentiatingvaccinereactionsfrominvasivebacterialinfectionsinyounginfantspresentingtotheemergencydepartmentinthe4cmenberaaretrospectiveobservationalcomparison
AT danieloconnor differentiatingvaccinereactionsfrominvasivebacterialinfectionsinyounginfantspresentingtotheemergencydepartmentinthe4cmenberaaretrospectiveobservationalcomparison
AT emilytough differentiatingvaccinereactionsfrominvasivebacterialinfectionsinyounginfantspresentingtotheemergencydepartmentinthe4cmenberaaretrospectiveobservationalcomparison
AT samuelwilliamchannonwells differentiatingvaccinereactionsfrominvasivebacterialinfectionsinyounginfantspresentingtotheemergencydepartmentinthe4cmenberaaretrospectiveobservationalcomparison